NCT05396833 2026-02-19Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)EMD SeronoPhase 1 Active not recruiting120 enrolled